{"id":34322,"title":"AF-16 in peritonitis induced sepsis","title_html":"<p>AF-16 in peritonitis induced sepsis<\/p>","image":{"source":"https:\/\/www.protocols.io\/img\/default_protocol.png","placeholder":"https:\/\/www.protocols.io\/img\/default_protocol.png"},"doi":"dx.doi.org\/10.17504\/protocols.io.bdrsi56e","doi_status":2,"uri":"af-16-in-peritonitis-induced-sepsis-bdrsi56e","type_id":1,"template_id":1,"published_on":1598112372,"parent_protocols":[],"parent_collections":[],"cited_protocols":[],"version_id":0,"created_on":1584358712,"categories":null,"creator":{"name":"Annelie Tenhunen","affiliation":null,"affiliations":[],"username":"annelie-tenhunen","note":null,"link":"https:\/\/doi.org\/10.1371\/journal.pone.0232302","image":{"source":"\/img\/avatars\/005.png","placeholder":"\/img\/avatars\/005.png"},"badges":[{"id":2,"image":{"source":"\/img\/badges\/bronze.svg","placeholder":"\/img\/badges\/bronze.svg"},"name":"Author"}],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"journal":"PLOS One","journal_name":"PLOS One","journal_link":"https:\/\/doi.org\/10.1371\/journal.pone.0232302","article_citation":"Tenhunen AB,  Heijden Jvd,  Blokhin I,  Massaro F,  Hansson HA,  Feinstein R,  Larsson A,  Larsson A,  Tenhunen J (2020) The antisecretory peptide AF-16 may modulate tissue edema but not inflammation in experimental peritonitis induced sepsis. PLoS ONE  15(8): e0232302. doi: <a target=\"_blank\" href=\"https:\/\/dx.doi.org\/10.1371\/journal.pone.0232302\">10.1371\/journal.pone.0232302<\/a> ","public":1,"has_versions":0,"link":"https:\/\/doi.org\/10.1371\/journal.pone.0232302","total_collections":0,"number_of_steps":14,"authors":[{"name":"Annelie Tenhunen","affiliation":"Dept of Surgical Sciences, Uppsala University, Uppsala, Sweden","affiliations":[],"username":"annelie-tenhunen","note":null,"link":null,"image":{"source":"\/img\/avatars\/005.png","placeholder":"\/img\/avatars\/005.png"},"badges":[],"verified":1,"is_verified_user":true,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false}],"versions":[],"groups":[],"is_owner":1,"has_subprotocols":0,"is_subprotocol":0,"is_bookmarked":0,"can_claim_authorship":0,"can_accept_authorship":0,"can_be_copied":1,"can_remove_fork":1,"fork_id":null,"url":"https:\/\/www.protocols.io\/view\/af-16-in-peritonitis-induced-sepsis-bdrsi56e","forks_count":{"private":0,"public":0},"access":{"can_view":1,"can_remove":0,"can_add":0,"can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":1,"can_move":1,"can_move_outside":1,"can_transfer":1,"can_download":1,"is_locked":0},"guid":"9BE3A580677A11EAA63DF15A99FD6238","state_version_id":1589,"steps":[{"id":897346,"guid":"241A8EA0677B11EAA63DF15A99FD6238","previous_id":null,"previous_guid":null,"modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"E50628FEAFCE4B0FBC419EF9AFFA2304","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"D2F8D5E29E1548649A6339F3FB5870FE","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">The animal is weighed. Premedication with Zoletil Forte (Tiletamin\/Zolazepam) 6 mg\/kg + Rompun (Xylazinklorid) 2.2 mg\/kg i.m in neck muscle. Establishment of a peripheral venous line in ear vein. Infusion Ringers' Acetate 30 ml\/kg\/h first hour, second hour until induction of peritonitis infusion with Ringers' Acetate 10 ml\/kg\/h.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":897347,"guid":"241CD890677B11EAA63DF15A99FD6238","previous_id":897346,"previous_guid":"241A8EA0677B11EAA63DF15A99FD6238","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"4CA411AF6FBC42CF8207DAEA31A02F82","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"CFAB0DBDBD0544CA8F0FC7930BD98783","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Animal placed supine. Induction with Fentanyl 5-10 \u00b5g\/kg.Tracheostomi. Maintenance with Ketamin 30 mg\/kg\/h, midazolam 0.1-0.4 mg\/kg\/h and fentanyl 4 \u00b5g\/kg\/h, dissolved in glucose 2.5%. Rocuronium (Esmeron) 2.5 mg\/kg\/h, when anesthesia is established (assured by absence of reaction to painful stimulation between the front hooves). <\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":897348,"guid":"241F4990677B11EAA63DF15A99FD6238","previous_id":897351,"previous_guid":"E2086CB0677C11EAA63DF15A99FD6238","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"90F842E7223C4340B8D7198762E953D7","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"CBB6B7E0174E4E21940EB1324FF4D227","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Instrumentation: Arterial catheter in the right carotid artery, pulmonary artery catheter and a triple lumen central venous catheter via the right jugular vein. A PiCCO catheter inserted in the right femoral artery. <\/div><div class = \"text-block\">Midline laparotomy and catheterization of the urinary bladder. Small incision in caecum to collect feces, close incision. Insert a large-bore intra-peritoneal drain in the peritoneum and close the abdominal incision. <\/div><div class = \"text-block\">Feces 2 g\/kg BW to be dissolved in 200 ml 5% glucose solution, store in <\/div><div class = \"text-block\"> until instillation in the peritoneum.<\/div><\/div>"}},{"id":1054725,"guid":"37FEF7C0678111EAA63DF15A99FD6238","order_id":2,"type_id":24,"title":"temperature","source":{"temperature":38,"unit":"\u00b0C","title":""}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":897349,"guid":"24222FC0677B11EAA63DF15A99FD6238","previous_id":897348,"previous_guid":"241F4990677B11EAA63DF15A99FD6238","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"C599F15ADBC0449EAA8CE1FD6634A6CB","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"FAD444197B314755A5B104ABEFC52030","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Preparation followed by at least 30 min of stabilization.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":897351,"guid":"E2086CB0677C11EAA63DF15A99FD6238","previous_id":897347,"previous_guid":"241CD890677B11EAA63DF15A99FD6238","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"4A3E361498AF40979500B692296DC184","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"170CD975104045E38A041F521D47647F","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>Volume controlled ventilation with the following settings: tidal volume (V<\/span><span style = \"vertical-align:sub;\">T<\/span><span>) 8 ml\/kg, respiratory rate (RR) 25\/min, inspiratory\/expiratory time (I:E) 1:2, inspired oxygen concentration (F<\/span><span style = \"vertical-align:sub;\">I<\/span><span style = \"vertical-align:sub;vertical-align:sub;\">O<\/span><span style = \"vertical-align:sub;\">2<\/span><span>) 0.3 and positive end-expiratory pressure (PEEP) 8 cmH<\/span><span style = \"vertical-align:sub;\">2<\/span><span>O; V<\/span><span style = \"vertical-align:sub;\">T<\/span><span>, I:E and PEEP were maintained constant throughout the protocol. F<\/span><span style = \"vertical-align:sub;\">I<\/span><span style = \"vertical-align:sub;vertical-align:sub;\">O<\/span><span style = \"vertical-align:sub;\">2 <\/span><span>adjusted with aim at PaO<\/span><span style = \"vertical-align:sub;\">2 <\/span><span>>10 kPa. Respiratory rate to adjust PaCO<\/span><span style = \"vertical-align:sub;\">2 <\/span><span><6,5 kPa.<\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":897374,"guid":"7FD29250678111EAA63DF15A99FD6238","previous_id":897349,"previous_guid":"24222FC0677B11EAA63DF15A99FD6238","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"F35DE4E773F343978EE9D8B2F57ECC13","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"B84210EC064E4BF6AD8F14CDF5DD6B02","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>Baseline measurements: arterial and mixed venous blood gas analyses, hemodynamic parameters (systemic and pulmonary pressures, cardiac output, heart rate), respiratory parameters (F<\/span><span style = \"vertical-align:sub;\">I<\/span><span style = \"vertical-align:sub;vertical-align:sub;\">O<\/span><span style = \"vertical-align:sub;\">2<\/span><span>, SaO<\/span><span style = \"vertical-align:sub;\">2<\/span><span>, ETCO<\/span><span style = \"vertical-align:sub;\">2<\/span><span>, plateau pressure, dynamic and static compliance) urinary output. Extra vascular lung water (EVLW) and stroke volume variation (SVV).<\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":897375,"guid":"835CA370678111EAA63DF15A99FD6238","previous_id":897374,"previous_guid":"7FD29250678111EAA63DF15A99FD6238","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"8E50B8041BA14173A480880868734F60","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"11070DE003ED488BA74FF40AF9E61DEA","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Induction of fecal peritonitis. Remove intraperitoneal drain and close abdominal wall. With induction of fecal peritonitis the infusion of Ringer\u2019s Acetate is discontinued.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":897377,"guid":"5FEF7740678211EAA63DF15A99FD6238","previous_id":897375,"previous_guid":"835CA370678111EAA63DF15A99FD6238","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"14F41227F416461FAAC584B4E2E90414","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"1395736EF15549139415484EA68F30E2","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Randomization: AF-16 (n=8) and control group (n=8), (block randomization: 4x4 sealed, opaque envelopes). The research team blinded for group allocation. <\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":897383,"guid":"921E56E0678311EAA63DF15A99FD6238","previous_id":897377,"previous_guid":"5FEF7740678211EAA63DF15A99FD6238","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"7DAD9590D0E94FD5ACFA5A44C9440368","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"49FB3F9FFCDD4261A6E1D93FE2C6DB22","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>Onset of hemodynamic instability (individual time of peritonitis) (defined as MAP <60 mmHg for >5 min). Parameters (see point 6: arterial blood gas analyses, hemodynamic parameters (systemic and pulmonary pressures, cardiac output, heart rate), respiratory parameters (F<\/span><span style = \"vertical-align:sub;\">I<\/span><span style = \"vertical-align:sub;vertical-align:sub;\">O<\/span><span style = \"vertical-align:sub;\">2<\/span><span>, SaO<\/span><span style = \"vertical-align:sub;\">2<\/span><span>, ETCO<\/span><span style = \"vertical-align:sub;\">2<\/span><span>, plateau pressure, dynamic and static compliance) and urine output measured hourly from this timepoint). SVV measured continuosly. EVLW and mixed venous blood gas analyses performed now and every three hours for the rest of the protocol).<\/span><\/div><div class = \"text-block\">After parameters: intervention group receives an initial bolus of AF-16, 20 mg\/kg (50 mg\/ml in 0.9% saline), over duration of 10 minutes, followed by an infusion of 40 mg\/kg over 50 minutes. The control group receives equal volumes of vehicle (0.9% saline) instead. After four and eight hours bolus dose is repeated (AF-16 or vehicle). <\/div><div class = \"text-block\">Piperacillin\/Tazobactam 2 gram every 8 hours i.v. with start after onset of hemodynamic instability.<\/div><div class = \"text-block\">Initiate protocolized resuscitation in both intervention and control groups.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":897386,"guid":"B136E410678411EAA63DF15A99FD6238","previous_id":897383,"previous_guid":"921E56E0678311EAA63DF15A99FD6238","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"39D60FF05A6F4300AAB456FD4AB43B7F","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"842E97148FB04B5BB8CFFF36A587456A","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Protocolized resuscitation:<\/div><div class = \"text-block\">Aiming at MAP > 60 mmHg. Start fluid resuscitation with Ringer\u2019s Acetate 10 ml\/kg\/h. <\/div><div class = \"text-block\">If signs of hypovolemia (SVV > 15% maintained for 10 min) a bolus of 150 ml Ringer\u2019s Acetate was administered. Fluid boluses are repeated until SVV is stable < 15%. When SVV decreases to < 13% with MAP >60 mmHg, infusion down to 5 ml\/kg\/h, and if the animal stable and SVV maintained < 13%, stop infusion. If signs of hypovolemia again appear, start infusion with 5 ml\/kg\/h, then 10 ml\/kg\/h, then administer boluses of 150 ml. <\/div><div class = \"text-block\">In case of hypotension (MAP < 60 mmHg) without increased SVV, start infusion of norepinephrine 5 ml\/h (40 \u00b5g\/ml) following a bolus of 1 ml (40 \u00b5g\/ml), increase stepwise by 5 ml\/h. <\/div><div class = \"text-block\">Administer glucose 30 % infusion, aiming at blood glucose 5-10 mmol\/L, starting with 0.5 ml\/kg\/h. If b-glucose > 10 mmol\/L start an insulin infusion 1E\/ml with 1 ml\/h.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":897403,"guid":"C83410D0678811EAA63DF15A99FD6238","previous_id":897386,"previous_guid":"B136E410678411EAA63DF15A99FD6238","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"7F5FF10B5AD84AD5AE4420E0F0F851F3","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"39C6FF0E9DB846C9974BF3AC09C404E5","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">After 20 hours after onset of hemodynamic instability. The animals are euthanized with 100 mmol KCl i.v. under deep anesthesia. If animals present with refractory shock and die before finishing protocol give 100 mmol Kcl i.v. when animal is terminal. <\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":897405,"guid":"5E5B3E80678911EAA63DF15A99FD6238","previous_id":897403,"previous_guid":"C83410D0678811EAA63DF15A99FD6238","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"719CC97E0D1B4E0CB87A6863F8572FC1","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"408962F377B74BDE9A9EAFBD02ABD005","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Animal is weighed.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":897406,"guid":"5E60E3D0678911EAA63DF15A99FD6238","previous_id":897405,"previous_guid":"5E5B3E80678911EAA63DF15A99FD6238","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"5799C0092FAF494BBA15281FE75EE3C9","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"E80177ED20B4444AB2A9D4BAE48F2AD8","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Samples are taken from lungs from following regions: apical-medial, medial-medial, caudal-dorsal, caudal-medial and caudal-ventral. Samples are also taken from heart, liver, kidney, intestine and skin. The samples are immediately immersed in 10% buffered formalin for histology and for wet-to-dry ratio.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":[],"critical_id":null,"duration":0},{"id":897407,"guid":"5E66B030678911EAA63DF15A99FD6238","previous_id":897406,"previous_guid":"5E60E3D0678911EAA63DF15A99FD6238","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"5E7971B0E90041088540AD54059F7534","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"5A8E58BBD1024E85B7B5B22C67F20445","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Samples for wet-to-dry ratio are measured in the above mentioned lung regions from the right lung, and from other mentioned organs. Samples are weighed, dried in an oven, at 50\u00b0 C, until weight do not differ between two measurements.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":[],"critical_id":null,"duration":0}],"document":null,"materials":[],"description":"<div class = \"text-blocks\"><div class = \"text-block\"><div class = \"justify\" style = \"text-align:justify\">Sepsis is a life-threatening condition due to a dysregulated immunological response to infection. Apart from source control and broad-spectrum antibiotics, management is based on fluid resuscitation and vasoactive drugs. Fluid resuscitation implicates the risk of volume overload, which in turn is associated with longer stay in intensive care, prolonged use of mechanical ventilation and increased mortality.<\/div><style>\n\t\t\t\t\t\t\t  .justify:after {\n\t\t\t\t\t\t\t    content: \"\";\n\t\t\t\t\t\t\t    display:inline-block;\n\t\t\t\t\t\t\t    width: 100%;\n\t\t\t\t\t\t\t  }\n\t\t\t\t\t\t\t<\/style><\/div><div class = \"text-block\"><div class = \"justify\" style = \"text-align:justify\">Antisecretory factor (AF), an endogenous protein, is detectable in most tissues and in plasma. The biologically active site of the protein is located inan 8-peptide sequence, contained in a synthetic 16-peptide fragment, named AF-16. The protein as well as the peptide AF-16 has multiple modulatory effects on abnormal fluid transport and edema formation\/resolution as well as in a variety of inflammatory conditions. Apart from its\u2019 anti-secretory and anti-inflammatory characteristics, AF is an inhibitor of capillary leakage in intestine. It is not known whether the protein AF or the peptide AF-16 can ameliorate symptoms in sepsis. We hypothesized that AF-16 decreases the degree of hemodynamic instability, the need of fluid resuscitation, vasopressor dose and tissue edema in fecal peritonitis. <\/div><style>\n\t\t\t\t\t\t\t  .justify:after {\n\t\t\t\t\t\t\t    content: \"\";\n\t\t\t\t\t\t\t    display:inline-block;\n\t\t\t\t\t\t\t    width: 100%;\n\t\t\t\t\t\t\t  }\n\t\t\t\t\t\t\t<\/style><\/div><div class = \"text-block\"><div class = \"justify\" style = \"text-align:justify\">To test the hypothesis, we induced peritonitis and sepsis by injecting autologous fecal solution into abdominal cavity of anesthetized pigs, and randomized (in a blind manner) the animals to intervention (AF-16, n=8) or control (saline, n=8) group. After onset of hemodynamic instability (defined as mean arterial pressure < 60 mmHg maintained for > 5 minutes), resuscitation was initiated by an infusion of AF-16 or saline. We recorded respiratory and hemodynamic parameters hourly for twenty hours and collected post mortem tissue samples at the end of the experiment. <\/div><style>\n\t\t\t\t\t\t\t  .justify:after {\n\t\t\t\t\t\t\t    content: \"\";\n\t\t\t\t\t\t\t    display:inline-block;\n\t\t\t\t\t\t\t    width: 100%;\n\t\t\t\t\t\t\t  }\n\t\t\t\t\t\t\t<\/style><\/div><div class = \"text-block\">No differences between the groups were observed regarding hemodynamics, fluid balance, lung mechanics, gas exchange or histology. This experimental study suggests that AF-16 does not modulate sepsis symptoms in peritonitis induced sepsis.<\/div><\/div>","changed_on":1598112372}